帕博利珠单抗诱导的伴有黑素细胞清除的亚急性皮肤型红斑狼疮。 - Suppr

Suppr

超能文献

Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab.

作者信息

Ogawa-Momohara Mariko, Muro Yoshinao, Goto Katsunobu, Obuse Chikashi, Satoh Minoru, Kono Michihiro, Akiyama Masashi

机构信息

Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Department of Biological Science, Graduate School of Science, Osaka University, Osaka, Japan.

出版信息

J Dermatol. 2020 Jun;47(6):e217-e219. doi: 10.1111/1346-8138.15316. Epub 2020 Mar 15.

DOI:10.1111/1346-8138.15316

PMID:32173880

Abstract

摘要

相似文献

Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab.

J Dermatol. 2020 Jun;47(6):e217-e219. doi: 10.1111/1346-8138.15316. Epub 2020 Mar 15.

Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy.

Eur J Cancer. 2021 Mar;145:168-170. doi: 10.1016/j.ejca.2020.12.017. Epub 2021 Jan 21.

Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.

Br J Dermatol. 2019 Sep;181(3):580-583. doi: 10.1111/bjd.17245. Epub 2018 Dec 10.

How frequently are drugs associated with the development or exacerbation of subacute cutaneous lupus?

Arch Dermatol. 2003 Jan;139(1):89-90. doi: 10.1001/archderm.139.1.89.

Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma: A multi-institutional retrospective study.

J Dermatol. 2020 Jun;47(6):629-635. doi: 10.1111/1346-8138.15345. Epub 2020 Apr 10.

Narrowband ultraviolet B therapy for refractory immune-related lichenoid dermatitis on PD-1 therapy: a case report.

J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001831.

Omeprazole-Induced Subacute Cutaneous Lupus Erythematosus.

JAMA Dermatol. 2020 Sep 1;156(9):1013. doi: 10.1001/jamadermatol.2020.2415.

Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.

J Dermatol. 2017 Oct;44(10):e240-e241. doi: 10.1111/1346-8138.13940. Epub 2017 Jul 5.

Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.

Lupus. 2021 Mar;30(3):531-533. doi: 10.1177/0961203320983448. Epub 2021 Jan 6.

Novel Onset of Cutaneous Lupus Erythematosus Induced by Pembrolizumab.

Acta Derm Venereol. 2024 Sep 30;104:adv40801. doi: 10.2340/actadv.v104.40801.

引用本文的文献

Novel Onset of Cutaneous Lupus Erythematosus Induced by Pembrolizumab.

Acta Derm Venereol. 2024 Sep 30;104:adv40801. doi: 10.2340/actadv.v104.40801.

Immune Checkpoint Inhibitors and Lupus Erythematosus.

Pharmaceuticals (Basel). 2024 Feb 15;17(2):252. doi: 10.3390/ph17020252.

Immune checkpoint inhibitor-induced subacute cutaneous lupus erythematosus: a case report and review of the literature.

Front Med (Lausanne). 2024 Feb 1;11:1334718. doi: 10.3389/fmed.2024.1334718. eCollection 2024.

Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by Durvalumab: A Case Report and Literature Review.

Clin Cosmet Investig Dermatol. 2022 Jan 13;15:51-62. doi: 10.2147/CCID.S344445. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab.

作者信息

Ogawa-Momohara Mariko, Muro Yoshinao, Goto Katsunobu, Obuse Chikashi, Satoh Minoru, Kono Michihiro, Akiyama Masashi

机构信息

Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Department of Biological Science, Graduate School of Science, Osaka University, Osaka, Japan.

出版信息

J Dermatol. 2020 Jun;47(6):e217-e219. doi: 10.1111/1346-8138.15316. Epub 2020 Mar 15.

DOI:10.1111/1346-8138.15316

PMID:32173880

Abstract

摘要

相似文献

Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab.

J Dermatol. 2020 Jun;47(6):e217-e219. doi: 10.1111/1346-8138.15316. Epub 2020 Mar 15.

Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy.

Eur J Cancer. 2021 Mar;145:168-170. doi: 10.1016/j.ejca.2020.12.017. Epub 2021 Jan 21.

Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.

Br J Dermatol. 2019 Sep;181(3):580-583. doi: 10.1111/bjd.17245. Epub 2018 Dec 10.

How frequently are drugs associated with the development or exacerbation of subacute cutaneous lupus?

Arch Dermatol. 2003 Jan;139(1):89-90. doi: 10.1001/archderm.139.1.89.

Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma: A multi-institutional retrospective study.

J Dermatol. 2020 Jun;47(6):629-635. doi: 10.1111/1346-8138.15345. Epub 2020 Apr 10.

Narrowband ultraviolet B therapy for refractory immune-related lichenoid dermatitis on PD-1 therapy: a case report.

J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001831.

Omeprazole-Induced Subacute Cutaneous Lupus Erythematosus.

JAMA Dermatol. 2020 Sep 1;156(9):1013. doi: 10.1001/jamadermatol.2020.2415.

Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.

J Dermatol. 2017 Oct;44(10):e240-e241. doi: 10.1111/1346-8138.13940. Epub 2017 Jul 5.

Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.

Lupus. 2021 Mar;30(3):531-533. doi: 10.1177/0961203320983448. Epub 2021 Jan 6.

Novel Onset of Cutaneous Lupus Erythematosus Induced by Pembrolizumab.

Acta Derm Venereol. 2024 Sep 30;104:adv40801. doi: 10.2340/actadv.v104.40801.

引用本文的文献

Novel Onset of Cutaneous Lupus Erythematosus Induced by Pembrolizumab.

Acta Derm Venereol. 2024 Sep 30;104:adv40801. doi: 10.2340/actadv.v104.40801.

Immune Checkpoint Inhibitors and Lupus Erythematosus.

Pharmaceuticals (Basel). 2024 Feb 15;17(2):252. doi: 10.3390/ph17020252.

Immune checkpoint inhibitor-induced subacute cutaneous lupus erythematosus: a case report and review of the literature.

Front Med (Lausanne). 2024 Feb 1;11:1334718. doi: 10.3389/fmed.2024.1334718. eCollection 2024.

Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by Durvalumab: A Case Report and Literature Review.

Clin Cosmet Investig Dermatol. 2022 Jan 13;15:51-62. doi: 10.2147/CCID.S344445. eCollection 2022.